Skip to content

In-hospital Cardiac Arrest - Dynamics and State Transitions

Dynamics and State Transitions During Resuscitation in In-hospital Cardiac Arrest

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00920244
Enrollment
285
Registered
2009-06-15
Start date
2009-08-31
Completion date
2015-04-30
Last updated
2018-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death, Sudden, Cardiac, Heart Arrest

Keywords

Resuscitation, Cardiac arrest, State-transitions, Markov

Brief summary

The purpose of this study is to analyse transitions in cardiac rhythm and hemodynamic variables during resuscitation of patients with in-hospital cardiac arrest.

Detailed description

In-hospital cardiac arrest carries a grave prognosis, with survival to discharge in the range of 15-20%. Key factors determining outcome include the presenting cardiac rhythm, aetiology, and early initiation of resuscitation. Some cardiac rhythms benefit from defibrillation (shockable rhythms). During resuscitation patients may switch between shockable and non-shockable rhythms, and may show signs of spontaneous circulation temporarily. Depending on rhythm and according to guidelines, patients receive direct current (DC) shocks (defibrillator) and/or i.v. adrenaline, atropine and amiodarone, which may affect state-transitions. We wish to make statistical analysis (time-series analysis, Markov modelling) of these state-transitions and variations in hemodynamic variables during resuscitation, related to CPR interventions and the cause of arrest. The cause of arrest will be determined based on chart records, interview with staff and autopsy if appropriate. One hypothesis is that differences in the patterns of state-transitions may reflect underlying aetiology, which may guide in future decision-making during resuscitation.

Interventions

PROCEDURECardiopulmonary resuscitation (CPR)

CPR is performed according to international and national guidelines on all patients.

DRUGEpinephrine

According to guidelines epinephrine 1 mg i.v. is administered every 3 minutes during cardiopulmonary resuscitation.

DRUGAtropine

According to CPR guidelines atropine 3 mg i.v. is administered if asystole og PEA with frequency \< 60 beat/min.

DRUGAmiodarone

According to guidelines amiodarone 300 mg i.v. is administered if recurrent ventricular fibrillation/tachycardia (VF/VT) during CPR.

DEVICEExternal defibrillator

According to CPR guidelines patients with shockable rhythms may receive DC shocks. The defibrillator also stores physiological information regarding cardiac rhythm, pulse-oximetry, and end-tidal carbon dioxide (CO2) from endotracheal tube.

Sponsors

Norwegian Air Ambulance Foundation
CollaboratorOTHER
Norwegian University of Science and Technology
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with in-hospital cardiac arrest who are resuscitated

Exclusion criteria

* Younger than 18 years old

Design outcomes

Primary

MeasureTime frame
Survival to discharge1 year

Secondary

MeasureTime frame
Short-term survivalminutes-days

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026